Servier today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation's 2025 Prix Galien USA Award for Best Product for Orphan/Rare Disease. The award was presented during a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback